Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Oculogica, Inc. See All Filings	D	2024-05-13 15:15:37 UTC
Amount To Be Raised $17,952,926 Associated Brokers / Dealers N/A CIK Number 0001613810 Filed Document 0001613810-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-05-13 15:15:37 UTC Type of Offering D Industry Biotechnology Principal Place of Business WISCONSIN Revenue or Assets Decline to Disclose Type of Security Equity
Oculogica, Inc. See All Filings	D	2022-06-23 14:38:19 UTC
Amount To Be Raised $4,500,000 Associated Brokers / Dealers N/A CIK Number 0001613810 Filed Document 0001613810-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-06-23 14:38:19 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Oculogica, Inc. See All Filings	D	2020-01-03 13:44:34 UTC
Amount To Be Raised $8,571,753 Associated Brokers / Dealers N/A CIK Number 0001613810 Filed Document 0001613810-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-01-03 13:44:34 UTC Type of Offering D Industry Other Health Care Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Oculogica, Inc. See All Filings	D	2016-03-17 00:00:00 UTC
Amount To Be Raised $2,500,000 Associated Brokers / Dealers N/A CIK Number 0001613810 Filed Document 0001613810-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-03-17 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Oculogica, Inc. See All Filings	D	2014-07-16 00:00:00 UTC
Amount To Be Raised $999,999 Associated Brokers / Dealers N/A CIK Number 0001613810 Filed Document 0000905718-14-000433 Exclusions or Exemptions 506b Accepted Date 2014-07-16 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity